» Articles » PMID: 34079714

The Feasibility of Non-contrast-enhanced Zero Echo Time Magnetic Resonance Angiography for Characterization of Intracranial Atherosclerotic Disease

Overview
Specialty Radiology
Date 2021 Jun 3
PMID 34079714
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Accurate and non-invasive assessment of intracranial atherosclerotic disease (ICAD) is important because of its effect on treatment planning. The aim of this study is to investigate if zero echo time (zTE) magnetic resonance angiography (zTE-MRA) is feasible in the characterization of ICAD.

Methods: A total of 175 patients with ICAD were recruited. ZTE-MRA and time-of-flight (TOF)-MRA sequences were conducted for all participants using a 3T clinical MR system. Forty-one patients also underwent digital subtraction angiography (DSA), and were confirmed to have intracranial arterial stenosis (ICAS). Weighted kappa (κ) statistics were used to assess the inter-observer agreement and diagnostic consistency of both zTE- and TOF-MRA, using DSA as a reference. The Wilcoxon signed-rank test was used to evaluate differences in image quality between zTE- and TOF-MRA images. The nonparametric test of multiple paired samples was used to compare the results of vascular stenosis diagnosis between zTE-, TOF-MRA and DSA.

Results: Supported by high inter-observer agreement (weighted κ=0.78), zTE-MRA generated significantly higher scores than TOF-MRA for susceptibility artifact signal (mean: 3.03±0.98 2.72±1.09; P=0.017) and flow signal in parent artery (mean: 3.63±0.49 3.07±0.82; P<0.001). Additionally, zTE-MRA showed more robust diagnostic performance than TOF-MRA for patients with ICAD and degree of vascular stenosis (P<0.05), and was highly consistent with reference DSA images (weighted κ=0.80).

Conclusions: ZTE-MRA has potential for use as a routine clinical method for patients with ICAD.

Citing Articles

Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease.

Chen L, Spagnolo-Allende A, Yang D, Qiao Y, Gutierrez J Stroke. 2024; 55(2):311-323.

PMID: 38252756 PMC: 10827355. DOI: 10.1161/STROKEAHA.123.043630.


Making the invisible visible-ultrashort echo time magnetic resonance imaging: Technical developments and applications.

Ma Y, Jang H, Jerban S, Chang E, Chung C, Bydder G Appl Phys Rev. 2022; 9(4):041303.

PMID: 36467869 PMC: 9677812. DOI: 10.1063/5.0086459.


Multimodal imaging approach for the diagnosis of intracranial atherosclerotic disease (ICAD): Basic principles, current and future perspectives.

Charles J, Desai S, Jean Paul A, Hassan A Interv Neuroradiol. 2022; 30(1):105-119.

PMID: 36262087 PMC: 10956456. DOI: 10.1177/15910199221133170.


Assessment of Solid Pulmonary Nodules or Masses Using Zero Echo Time MR Lung Imaging: A Prospective Head-to-Head Comparison With CT.

Liu Q, Feng Z, Liu W, Fu W, He L, Cheng X Front Oncol. 2022; 12:812014.

PMID: 35558517 PMC: 9088008. DOI: 10.3389/fonc.2022.812014.

References
1.
Shang S, Ye J, Dou W, Luo X, Qu J, Zhu Q . Validation of Zero TE-MRA in the Characterization of Cerebrovascular Diseases: A Feasibility Study. AJNR Am J Neuroradiol. 2019; 40(9):1484-1490. PMC: 7048437. DOI: 10.3174/ajnr.A6173. View

2.
Holmstedt C, Turan T, Chimowitz M . Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013; 12(11):1106-14. PMC: 4005874. DOI: 10.1016/S1474-4422(13)70195-9. View

3.
Wei L, Zhu Y, Bao Y, Lu H, Zhang P, Zhao Y . Atherosclerosis in intracranial or extracranial vessels in diabetic patients and the association with stroke subtype. Quant Imaging Med Surg. 2019; 9(6):960-967. PMC: 6629560. DOI: 10.21037/qims.2019.04.17. View

4.
Feldmann E, Daneault N, Kwan E, Ho K, Pessin M, Langenberg P . Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990; 40(10):1541-5. DOI: 10.1212/wnl.40.10.1540. View

5.
Prestigiacomo C, Sabit A, He W, Jethwa P, Gandhi C, Russin J . Three dimensional CT angiography versus digital subtraction angiography in the detection of intracranial aneurysms in subarachnoid hemorrhage. J Neurointerv Surg. 2011; 2(4):385-9. DOI: 10.1136/jnis.2010.002246. View